Currently, there are 273.40M common shares owned by the public and among those 253.25M shares have been available to trade.
The company’s stock has a 5-day price change of 2.10% and 23.79% over the past three months. MSTR shares are trading 42.75% year to date (YTD), with the 12-month market performance up to 174.98% higher. It has a 12-month low price of $102.40 and touched a high of $543.00 over the same period. MSTR has an average intraday trading volume of 18.35 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 6.51%, 24.36%, and 47.64% respectively.
Institutional ownership of Strategy (NASDAQ: MSTR) shares accounts for 45.64% of the company’s 273.40M shares outstanding.
It has a market capitalization of $113.03B and a beta (3y monthly) value of 3.75. The earnings-per-share (ttm) stands at -$21.81. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.78% over the week and 4.84% over the month.
Analysts forecast that Strategy (MSTR) will achieve an EPS of -0.03 for the current quarter, -0.05 for the next quarter and -0.22 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.03 while analysts give the company a high EPS estimate of -0.03. Comparatively, EPS for the current quarter was -0.76 a year ago. Earnings per share for the fiscal year are expected to decrease by -168.61%, and 97.61% over the next financial year.
Looking at the support for the MSTR, a number of firms have released research notes about the stock. H.C. Wainwright stated their Buy rating for the stock in a research note on April 29, 2025, with the firm’s price target at $480. Monness Crespi & Hardt coverage for the Strategy (MSTR) stock in a research note released on April 01, 2025 offered a Sell rating with a price target of $220. Monness Crespi & Hardt was of a view on March 19, 2025 that the stock is Neutral, while Keefe Bruyette gave the stock Outperform rating on February 07, 2025, issuing a price target of $560. Mizuho on their part issued Outperform rating on January 29, 2025.
